advertisement

---

Malvankar-Mehta MS 6

Showing records 1 to 6 | Display all abstracts from Malvankar-Mehta MS

84884 North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Malvankar-Mehta MS
ClinicoEconomics and outcomes research : CEOR 2019; 11: 789-798

---

84965 Estimating patient-reported outcomes for glaucoma management: A cross-sectional study
Uruthiramoorthy L
Journal of evidence-based medicine 2020; 13: 8-16

---

84884 North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Feng L
ClinicoEconomics and outcomes research : CEOR 2019; 11: 789-798

---

84965 Estimating patient-reported outcomes for glaucoma management: A cross-sectional study
Hutnik CML
Journal of evidence-based medicine 2020; 13: 8-16

---

84884 North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Hutnik CM
ClinicoEconomics and outcomes research : CEOR 2019; 11: 789-798

---

84965 Estimating patient-reported outcomes for glaucoma management: A cross-sectional study
Speechley KN; Malvankar-Mehta MS; Lizotte DJ
Journal of evidence-based medicine 2020; 13: 8-16

---